Literature DB >> 15481804

Neuroendocrine hypothesis of aging: the role of corticoadrenal steroids.

G Valenti1.   

Abstract

The age-related modifications of neuroendocrine secretions normally capable of integrative activity in the whole body might partly promote and amplify many aging phenomena. The quantitative and qualitative changes of hypothalamus-pituitary-adrenal axis are a significant example. The dampening of cortisol and dehydroepiandrosterone (DHEA) circadian fluctuation and the progressive decrease of DHEA/cortisol ratio are at the basis of multiple clinical implications: the shift from anabolic to catabolic status, the activation of atherosclerosis progression, the deterioration of immune competence, the impairment of cognitive and affective performances and the glico- and lipometabolic disorders. The hypothesis of a DHEA supplementation strategy comes out from these premises.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15481804

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  3 in total

1.  Diurnal variation of cortisol in people with dementia: relationship to cognition and illness burden.

Authors:  Christine R Kovach; Diana Lynn Woods; Brent R Logan; Hershel Raff
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-01-27       Impact factor: 2.035

2.  Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke.

Authors:  Claudine A Blum; Cornelia Mueller; Philipp Schuetz; Felix Fluri; Michael Trummler; Beat Mueller; Mira Katan; Mirjam Christ-Crain
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

3.  Assessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling.

Authors:  Sandrine Ellero-Simatos; Ewa Szymańska; Ton Rullmann; Wim Ha Dokter; Raymond Ramaker; Ruud Berger; Thijs Mp van Iersel; Age K Smilde; Thomas Hankemeier; Wynand Alkema
Journal:  Genome Med       Date:  2012-11-30       Impact factor: 11.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.